. . . . . . . . . . . . . . "p(HGNC:IL6R) -> p(HGNC:IL6)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "We have shown that sIL-6Ra levels released by myeloma cells are correlated with disease progression, explaining in part the strong prognostic value of sIL-6Ra serum levels in patients with MM [6]. Of major interest is the fact that the sIL-6Ra is an agonist of IL-6 able to potentiate its activity #[JL] the only way I can think of to model this is that IL6R^IL6, since IL6 doesn't have an activity in itself" . . "Selventa" . . . . "2014-07-03T14:29:57.721+02:00"^^ . . .